Theratechnologies Inc T.TH

RE:RE:RE:RE:RE:RE:RE:RE:AGM was horrible

[palinc2000]

You state that the big miss in Trogarzo sales is spread over 2 Ceos ..... Tanguay guided for 500 million$ then 250 millions What did Paul guided and achieved?

SPCEO1 wrote: The share price now is obviously correlated to TH-1902. You got all the evidence you need to prove that on 12/1/22 and you may ahve  noticed the share price has perked up a little in the last six weeks or so on the back of the TH-1902 resubmission. Trogarzo's bad sales versus original expectations were the main reason for the share price decline prior to the TH-1902 pause. And that was a very bad miss spread out over two CEO's. As for what the main risk is right now, you may be right that letting the current team continue is the biggest risk but a good arguement can be made that it would be a bigger risk to upset the applecart right at this delicate time for TH-1902 and I opted for that approach. Time will tell if it was the best decision and I would be happily surprised if everything suddenly goes wonderfully well from this point forward. It will more likely be a situation where success is achieved by a longer, grinding process punctuated by setbacks here and there. So, it may never be clear which approach was best but at least the path we are now going on will be a bit less messy on the front end. My conversation with the board chair was mostly about what the group of voters I represented would like to see happen, not about the past or what the company's plans might be. They needed our votes and we made requests in exchange for those votes - requests that I beleive would benefit all shareholders without the need to cause a mess in the process. Those requests were not demands and I did not have her sign a committment to do them. It is up to the board to discuss and hopefully come up with something even better than I requested. They could ignore our recommendations altogether but that does not seem like a sensible thing for them to do. The board chair seems to me to be an intelligent person, TH-1902 likely does have a good future, the legacy drug sales are improving and, therefore, it is possible to see a good outcome for us all. Let's hope THTX makes even better moves than my group suggested and things start breaking their way. While we deserve a few lucky breaks, it is more likely going to be tougher than that.Still, the THTX story is not yet over and could yet have a happy ending. TH-1902 is the key to that and the recent PD-L1 research certainly adds a lot of potential to the TH-1902 story.  

Garp1 wrote:
It's not about TH-1902, it's about the share price and everything surronding the bad communication for the last three years, the missed sales projections, the failure to find a partner in anything, the constant postponment in the delivery process. I find it hard to believe that with your knowledge and background that  you can only perceive TH-1902 as the main culprit in the share price. The main risk was to let management continue with no consequence to their action. Your conversation with management just prior to the AGM deadline for submitting votes could not have and should not have contained prevy information that is of material value to shareholders. So all in all it could only have been a nice cosy fireside chat which should not have change your perspective.